Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease.
about
Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interactionCommensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injuryIdentification of Cd101 as a susceptibility gene for Novosphingobium aromaticivorans-induced liver autoimmunityLiver autoimmunity triggered by microbial activation of natural killer T cellsTrex1 prevents cell-intrinsic initiation of autoimmunityAutoimmune disease triggered by infection with alphaproteobacteriaRegulatory Role of IL-1R8 in Immunity and DiseaseIntracellular nucleic acid sensors and autoimmunityTLRs and interferons: a central paradigm in autoimmunityInnate immune recognition of HIV-1Methane limit LPS-induced NF-κB/MAPKs signal in macrophages and suppress immune response in mice by enhancing PI3K/AKT/GSK-3β-mediated IL-10 expressionThe dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunityThe peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectinIntracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase BtkZinc finger protein ZBTB20 promotes Toll-like receptor-triggered innate immune responses by repressing IκBα gene transcriptionHumanized Immunoglobulin Mice: Models for HIV Vaccine Testing and Studying the Broadly Neutralizing Antibody Problem.Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.The Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors.TLRs and IFNs: critical pieces of the autoimmunity puzzlePrevention of murine antiphospholipid syndrome by BAFF blockadeTargeting cell surface TLR7 for therapeutic intervention in autoimmune diseases.Natural killer T (NKT) cells in autoimmune hepatitisAn innate path to human B cell tolerance.IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosusRequirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexesExtraordinarily potent proinflammatory properties of lactoferrin-containing immunocomplexes against human monocytes and macrophages.Molecular control of steady-state dendritic cell maturation and immune homeostasis.Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosusDysregulated cytokine production by dendritic cells modulates B cell responses in the NZM2410 mouse model of lupusSignaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cellsHumanized TLR7/8 expression drives proliferative multisystemic histiocytosis in C57BL/6 mice.Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus.Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model.Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritisNETs: the missing link between cell death and systemic autoimmune diseases?Basement membrane and cell integrity of self-tissues in maintaining Drosophila immunological toleranceThe proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis.Regulation of adaptive immunity by the innate immune systemThe U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases.
P2860
Q24309134-0C3D13ED-E8EF-4E0D-931B-1838F5F69FEDQ24600221-4A591B0B-BF09-47CC-B0BC-EB6C027F3E00Q24633643-DE413834-0233-4D35-907E-D986D79F61FAQ24644772-BF27AB2E-1AE8-4ECB-AE22-72886B3CAC12Q24648757-4E583539-1702-4CB4-BA16-37B818CB7F9DQ24655779-F2CE4E3D-FA13-42C6-84E7-92722F6153CFQ26752524-B91E1A89-3241-4B10-B069-DFA50A030366Q26997316-5E0878B5-80CD-4893-8F40-329C78B8A464Q27023982-2A637DDF-0867-4F9A-8616-DB1958DCD76FQ27025598-F480E026-8036-4ED3-9421-6B14A756AF20Q28383990-2A50D155-B4BA-4ACC-9D17-458AF9C3977AQ28384138-ACEFA12A-2681-419C-9EFF-C62A2F33EDF2Q28585701-3CB7B83E-FB4F-47DA-8F9D-91262FE0F0D0Q28587736-FD445E85-CE47-484C-828A-467FC3F43D28Q28590069-DE83070B-3DC7-4B24-B2B9-9691BFF2444AQ30234773-1DD7A0B0-81E6-4775-A6F6-1B2BAD7CC01AQ30437086-05FE19E8-03CB-43A7-A90F-4D242607EB61Q30486741-97EC6C07-1701-4EE6-9F5A-E8C34DF1314DQ33354714-442E6BB2-73BD-403C-90A2-D6124D744A37Q33380975-209D0DBB-8934-4B3A-98CE-C8FFFB163D09Q33420162-ADB96654-3FA1-4673-8667-E35651024F0FQ33580295-3AA35D19-1EC5-43BD-AD70-974B08F9F029Q33596644-E2BF6913-B4B8-4458-846C-B6D97665D128Q33804141-2F302664-4C1A-4DFD-B2B7-AC19CD7BE5DCQ33815085-438D971D-5814-4686-8E31-C0A8FF5D2BFDQ33835332-44B9C303-6E0C-490D-A7D9-FEE5D9CFE792Q33882051-D66ECD33-D815-458A-B5A6-B000EBB0ECF5Q33889168-5DC79466-85DC-41A9-B748-0853A697939AQ33920964-90D3DE9A-4456-4661-9801-FA4CBFDB2A8AQ34004649-770C467B-66E7-47AA-BF67-1D9CCA1F2DAAQ34055580-BEA6F5FD-661C-4BC0-A75E-B8CAE69CF699Q34208023-A73B71C7-DDFE-4102-A86E-86BABB25825DQ34230520-8DD2375B-01A6-4E1E-82CC-2BA9F8A909A1Q34230589-648DAA28-B58F-4256-805C-44AA7466554CQ34290839-5EF02567-EF6F-4135-AC00-60593E37E3A9Q34323566-2469A04C-5C7B-43C2-AAB8-E6BCF39F6481Q34350852-300E721A-A458-4E82-8980-509AC0EE9CC9Q34360138-01CCEAB3-A80A-498B-8527-32803233FF89Q34659642-6B1F5991-7E6C-4664-BDE7-C752E3DB198BQ34779998-AACE6503-5AE6-4BA9-8A0A-DC906621BFB4
P2860
Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Immunologically active autoant ...... chronic inflammatory disease.
@ast
Immunologically active autoant ...... chronic inflammatory disease.
@en
type
label
Immunologically active autoant ...... chronic inflammatory disease.
@ast
Immunologically active autoant ...... chronic inflammatory disease.
@en
prefLabel
Immunologically active autoant ...... chronic inflammatory disease.
@ast
Immunologically active autoant ...... chronic inflammatory disease.
@en
P1476
Immunologically active autoant ...... f chronic inflammatory disease
@en
P2093
Ann Marshak-Rothstein
P304
P356
10.1146/ANNUREV.IMMUNOL.22.012703.104514
P50
P577
2007-01-01T00:00:00Z